Welcure Drugs and Pharmaceuticals Limited (BOM:524661)
India
· Delayed Price · Currency is INR 0.280
-0.010 (-3.45%)
At close: Mar 10, 2026
BOM:524661 Revenue
Welcure Drugs and Pharmaceuticals had revenue of 3.66B INR in the twelve months ending December 31, 2025, up 994.82% year-over-year. In the fiscal year ending March 31, 2025, Welcure Drugs and Pharmaceuticals had annual revenue of 245.50M.
Revenue (ttm)
3.66B
Revenue Growth
+994.82%
P/S Ratio
0.10
Revenue / Employee
n/a
Employees
n/a
Market Cap
358.42M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| JFL Life Sciences | 744.78M |
| Murae Organisor | 8.59B |
| Sandu Pharmaceuticals | 671.50M |
| Vista Pharmaceuticals | 86.30M |
| Deccan Health Care | 816.77M |
| Panjon | 493.34M |
| ANG Lifesciences India | 862.13M |
| Gujarat Terce Laboratories | 483.98M |